Mar 22, 2010

What will meetings look like in 2020? That’s the big question on the minds of analysts at Fast Future Research, a London-based global research and consulting firm, who are in the midst of a multiphase study called Convention 2020. The results of...

Healthcare Reform, Public Perception Mean Greater Scrutiny of Pharma Meetings

Mar 18, 2010

How legislative healthcare reform efforts will affect pharmaceutical meetings.

Diet coke, dresses, and CME

Mar 17, 2010

What do these three things have to do with each other? Read this article for one of the weirdest conflict-of-interest stories I've heard in a while: Whose Red Dress? Docs Debate Diet Coke Logo

Medical Association Sees Nearly 50 Percent Spike in Attendance

Mar 17, 2010

At a time when many associations are seeing participation levels plummet, ADAA’s attendance jumped 43 percent at the association’s 2010 conference in Baltimore

On the Map: STR Global Tracking 12 New Destinations

Mar 16, 2010

Here’s one way to know you’ve really arrived as a destination: STR Global starts reporting on you...

Duffy to Pharma Planners: Reposition the Meetings Industry

Mar 16, 2010

It’s time for meeting professionals to strategize, not hide. Speaking at the Sixth Annual Pharmaceutical Meeting Management Forum in Philadelphia, Christine Duffy, president and CEO, Martiz Travel, took issue with the way many companies initially...

IACC to Stream Thought Leader Summit

Mar 15, 2010

The International Association of Conference Centers’ Thought Leader Summit on Conference Technology convenes in downtown Chicago on March 24, and meeting professionals are invited to watch a live stream of the event, free of charge...

AIME Highlights Australia’s Good Fortune, Honors PCMA’s Sexton

Mar 15, 2010

Even though Australia is a world apart from the United States, the country shares a language (sort of) and a similar lifestyle and world outlook with us Yanks. But the land down under is way ahead of us in terms of economic recovery, something...

Connecticut Considers Pharma Bill SB 270

Mar 11, 2010

Connecticut is considering SB 270, a bill that seeks to limit physician-pharmaceutical industry interaction.